000 | 01403 a2200397 4500 | ||
---|---|---|---|
005 | 20250512030107.0 | ||
264 | 0 | _c19880803 | |
008 | 198808s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenthal, G J | |
245 | 0 | 0 |
_aSuppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJul 1988 |
||
300 |
_a410-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFolic Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aImmunoglobulins _xbiosynthesis |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aMethotrexate _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPurines _xantagonists & inhibitors |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aTrimetrexate |
700 | 1 | _aWeigand, G W | |
700 | 1 | _aGermolec, D R | |
700 | 1 | _aBlank, J A | |
700 | 1 | _aLuster, M I | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 141 _gno. 2 _gp. 410-6 |
|
999 |
_c2974239 _d2974239 |